Filing Details

Accession Number:
0001209191-14-067349
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-07 17:04:48
Reporting Period:
2014-11-05
Filing Date:
2014-11-07
Accepted Time:
2014-11-07 17:04:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1254419 Medassets Inc MDAS Services-Prepackaged Software (7372) 510391128
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1415810 A John Bardis 100 North Point Center East
Suite 200
Alpharetta GA 30022
Chairman, President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-11-05 62,486 $20.92 543,220 No 4 S Direct
Common Stock Disposition 2014-11-06 68,639 $20.84 474,581 No 4 S Direct
Common Stock Disposition 2014-11-07 60,708 $20.44 413,873 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,000 Indirect By Spouse
Restricted Stock 11,969 Direct
Restricted Stock 13,256 Direct
Restricted Stock 13,997 Direct
Restricted Stock Units 30,397 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.75 to $21.35, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.64 to $21.12, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.27 to $20.56, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.